1. Lu, Zhen, Mao, Weiqun, Yang, Hailing, Vankayalapati, Hariprasad, Bast, Robert C. . SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. In The Journal of clinical investigation, 132, . doi:10.1172/JCI146471. https://pubmed.ncbi.nlm.nih.gov/35642638/
2. Proteau, Sarah, Krossa, Imène, Husser, Chrystel, Bertolotto, Corine, Strub, Thomas. 2023. LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. In EMBO molecular medicine, 15, e17719. doi:10.15252/emmm.202317719. https://pubmed.ncbi.nlm.nih.gov/37966164/
3. Imielinski, Marcin, Berger, Alice H, Hammerman, Peter S, Getz, Gad, Meyerson, Matthew. . Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. In Cell, 150, 1107-20. doi:10.1016/j.cell.2012.08.029. https://pubmed.ncbi.nlm.nih.gov/22980975/
4. Yoon, Sung-Hee, Meyer, Mark B, Arevalo, Carlos, Mannstadt, Michael, Wein, Marc N. 2023. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. In The Journal of clinical investigation, 133, . doi:10.1172/JCI163627. https://pubmed.ncbi.nlm.nih.gov/36862513/
5. Dai, Xiao-Man, Zhang, Yan-Hui, Lin, Xiao-Han, Lin, Xin-Jian, Lin, Xu. 2020. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases. In Molecular oncology, 15, 228-245. doi:10.1002/1878-0261.12838. https://pubmed.ncbi.nlm.nih.gov/33128264/
6. Sasaki, Tsutomu, Takemori, Hiroshi, Yagita, Yoshiki, Sakoda, Saburo, Kitagawa, Kazuo. . SIK2 is a key regulator for neuronal survival after ischemia via TORC1-CREB. In Neuron, 69, 106-19. doi:10.1016/j.neuron.2010.12.004. https://pubmed.ncbi.nlm.nih.gov/21220102/
7. Muraoka, Masaaki, Fukushima, Aiko, Viengchareun, Say, Okamoto, Mitsuhiro, Takemori, Hiroshi. 2009. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. In American journal of physiology. Endocrinology and metabolism, 296, E1430-9. doi:10.1152/ajpendo.00024.2009. https://pubmed.ncbi.nlm.nih.gov/19351809/
8. Gao, Tian, Zhang, Xiaohong, Zhao, Jing, Li, Jibin, Liu, Shujuan. 2019. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. In Cancer letters, 469, 89-101. doi:10.1016/j.canlet.2019.10.029. https://pubmed.ncbi.nlm.nih.gov/31639424/
9. Park, Jinyoung, Yoon, Young-Sil, Han, Hye-Sook, Kim, Seong-Tae, Koo, Seung-Hoi. 2014. SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo. In Diabetes, 63, 3659-73. doi:10.2337/db13-1423. https://pubmed.ncbi.nlm.nih.gov/24898145/
智鼠故事 
